N-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-(1,2,4-triazol-1-yl)propanamide

C14H16N6O — CID 31124643

IUPACN-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-(1,2,4-triazol-1-yl)propanamide
SMILESO=C(CCn1cncn1)NCCc1cn2ccccc2n1
InChIInChI=1S/C14H16N6O/c21-14(5-8-20-11-15-10-17-20)16-6-4-12-9-19-7-2-1-3-13(19)18-12/h1-3,7,9-11H,4-6,8H2,(H,16,21)
InChIKeyIGSVNPHHEUENJE-UHFFFAOYSA-N
MW284.32 g/mol
LogP0.67
Rot. Bonds6

About N-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-(1,2,4-triazol-1-yl)propanamide

N-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-(1,2,4-triazol-1-yl)propanamide (PubChem CID 31124643) has the molecular formula C14H16N6O and a molecular weight of 284.32 g/mol. Its IUPAC name is N-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-(1,2,4-triazol-1-yl)propanamide.

Molecular Properties

Compound NameN-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-(1,2,4-triazol-1-yl)propanamide
PubChem CID31124643
Molecular FormulaC14H16N6O
Molecular Weight284.32 g/mol
Exact Mass284.14
IUPAC NameN-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-(1,2,4-triazol-1-yl)propanamide
SMILESO=C(CCn1cncn1)NCCc1cn2ccccc2n1
InChIInChI=1S/C14H16N6O/c21-14(5-8-20-11-15-10-17-20)16-6-4-12-9-19-7-2-1-3-13(19)18-12/h1-3,7,9-11H,4-6,8H2,(H,16,21)
InChIKeyIGSVNPHHEUENJE-UHFFFAOYSA-N
XLogP0.67
TPSA77.11 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms21
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500284.32
LogP ≤ 50.67
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze N-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-(1,2,4-triazol-1-yl)propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-(benzimidazol-1-yl)-N-(2-imidazo[1,2-a]pyridin-2-ylethyl)propanamide
CID 37275239
N-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-(2-oxo-1,3-benzoxazol-3-yl)propanamide
CID 31008366
N-(2-imidazo[1,2-a]pyridin-2-ylethyl)-4-phenoxybutanamide
CID 31008224
1-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]urea
CID 55922211
3-(2-ethoxyphenyl)-N-(2-imidazo[1,2-a]pyridin-2-ylethyl)propanamide
CID 31008355
2-(4-ethoxyphenoxy)-N-(2-imidazo[1,2-a]pyridin-2-ylethyl)acetamide
CID 42017579
N-[2-(2,6-difluorophenyl)ethyl]-2-imidazo[1,2-a]pyridin-2-ylacetamide
CID 87006920
2-(4-tert-butylphenyl)sulfanyl-N-(2-imidazo[1,2-a]pyridin-2-ylethyl)acetamide
CID 31008586
N-(2-imidazo[1,2-a]pyridin-2-ylethyl)-4-methyl-1,4-diazepane-1-carboxamide
CID 71893430
2-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-(2-imidazo[1,2-a]pyridin-2-ylethyl)acetamide
CID 17493812
N-(3-amino-3-phenylpropyl)-3-(1,2,4-triazol-1-yl)propanamide
CID 80506321
4-fluoro-N-(2-imidazo[1,2-a]pyridin-2-ylethyl)benzamide
CID 25429046

Frequently Asked Questions

What is the IUPAC name of N-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-(1,2,4-triazol-1-yl)propanamide?
The IUPAC name of N-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-(1,2,4-triazol-1-yl)propanamide (CID 31124643) is N-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-(1,2,4-triazol-1-yl)propanamide.
What is the SMILES notation for N-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-(1,2,4-triazol-1-yl)propanamide?
The canonical SMILES for N-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-(1,2,4-triazol-1-yl)propanamide is O=C(CCn1cncn1)NCCc1cn2ccccc2n1.
What is the InChIKey of N-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-(1,2,4-triazol-1-yl)propanamide?
The InChIKey is IGSVNPHHEUENJE-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H16N6O/c21-14(5-8-20-11-15-10-17-20)16-6-4-12-9-19-7-2-1-3-13(19)18-12/h1-3,7,9-11H,4-6,8H2,(H,16,21).
What are the key properties of N-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-(1,2,4-triazol-1-yl)propanamide?
N-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-(1,2,4-triazol-1-yl)propanamide has a molecular weight of 284.32 g/mol, XLogP of 0.67, 6 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-(1,2,4-triazol-1-yl)propanamide is sourced from PubChem (CID 31124643), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).